Joel Lewis Galectin Therapeutics Inc (GALT) insider trading activity
Joel Lewis is President and CEO of GALECTIN THERAPEUTICS INC. Currently has a direct ownership of 832,592 shares of GALT, which is worth approximately $1.27 Million. The most recent transaction as insider was on Feb 26, 2021, when has been sold 7,440 shares (Common Stock) at a price of $2.24 per share, resulting in proceeds of $16,666. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
833K
7.18%
3M change
7.25%
12M change
Total Value Held
$1.27 Million
JOEL LEWIS Transaction History
JL
Joel Lewis
President and CEO
Norcross, GA